JAMA Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 23.9 | Q1 | 96.1% | 7.399 | Q1 | 99.5% |
| 2024 | 20.1 | Q1 | 96.0% | 8.377 | Q1 | 99.6% |
| 2023 | 22.5 | Q1 | 95.6% | 7.843 | Q1 | 99.6% |
| 2022 | 28.4 | Q1 | 96.3% | 8.103 | Q1 | 99.6% |
| 2021 | 33.0 | Q1 | 96.2% | 7.502 | Q1 | 99.6% |
| 2020 | — | — | 8.846 | Q1 | 99.7% | |
| 2019 | — | — | 7.593 | Q1 | 99.6% | |
| 2018 | — | — | 7.604 | Q1 | 99.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2374-2437
ISSN
2374-2445
region
Northern America
coverage
2015-2026